MOSCOW (MRC) -- Clariant’s Healthcare Polymer Solutions group has introduced new solutions for controlling moisture in pharmaceutical packaging, while Clariant Masterbatches introduced important new anti-static masterbatches for pharmaceutical films suring this global conference, which rook place this year at Messe Frankfurt from October 24-26, as per the company's press release.
The Clariant Healthcare Packaging business line manufactures controlled atmosphere packaging materials that help to protect healthcare products from humidity and oxygen. At CPhI Worldwide Frankfurt, the company announced expansion of its Equilibrium stabilizer products line, which maintain a specific, equilibrium relative humidity (ERH) range in drug products or ingredients. The company announced an expanded line of EQ-Pak packets, which join other solutions including EQ-CAN canisters, EQ-Stopper caps, and the EQ-Bag for bulk packages containing empty capsules, powders, or other moisture-sensitive product ingredients.
Clariant Masterbatches introduced a new amide/amine-free anti-static masterbatch concentrate, MEVOPUR PEAM 176045, for polyethylene films used in pharmaceutical applications. The new anti-stat is important and timely due to coming regulatory changes, specifically the need to comply with the new USP<665> regulation by 2020.
The rule will limit the acceptability of many of the currently used films that rely on ‘food-grade’ amide- and amine-based anti-stats. At that time, USP<665> will require plastics used in pharma manufacturing, including anti-static films, to comply with the same standards as plastics packaging used for finished pharmaceuticals. The new PEAM 176045 additive masterbatch concentrate is part of MEVOPUR brand of ‘Controlled, Consistent and Compliant’ products for plastics applications in the medical and pharmaceutical industries.
As MRC wrote previously, in March 2017, Clariant announced that it had been awarded a contract by Dongguan Grand Resource Science & Technology Co. Ltd. to develop a new propane dehydrogenation unit in cooperation with CB&I. The project includes the license and engineering design of the unit, which is to be built in Dongguan City, Guangdong Province, China. The Dongguan plant will be one of the largest single-train dehydrogenation units in the world. Clariant's technology partner CB&I will base the plant's design on its Catofin® catalytic dehydrogenation technology, which uses Clariant's tailor-made Catofin catalyst and Heat Generating Material (HGM).
Clariant AG is a Swiss chemical company and a world leader in the production of specialty chemicals for the textile, printing, mining and metallurgical industries. It is engaged in processing crude oil products in pigments, plastics and paints. Clariant India has local masterbatch production activities at Rania, Kalol and Nandesari (Gujarat) and Vashere (Maharashtra) sites in India.
MRC